[1]
“Comparison of efficacy and safety of teneligliptin versus sitagliptin as add on to metformin in type 2 diabetes mellitus at a tertiary care hospital”, Int. J. of Res. in Pharmacology &Pharmacotherapeutics , vol. 6, no. 2, pp. 208–217, Apr. 2021, doi: 10.61096/ijrpp.v6.iss2.2017.208-217.